Consolidation anti-CD22 fractionated radioimmunotherapy with 90 Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial - Archive ouverte HAL Access content directly
Journal Articles The Lancet Haematology Year : 2017

Consolidation anti-CD22 fractionated radioimmunotherapy with 90 Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial

, (1) , (2) , , , (3) , (4) , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , (13) , , (14) , (15) , , (16) , (17) , (18) , (19) , (20) , (21) , (22) , (22) , (23) , (24)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Francoise Kraeber-Bodere
  • Function : Author
Loïc Campion
  • Function : Author
  • PersonId : 982002
Anne Moreau
  • Function : Author
  • PersonId : 913458
Isabelle Soubeyran
Steven Le Gouill
  • Function : Author
  • PersonId : 892875
Emmanuel Gyan
  • Function : Author
Sophie Sadot
  • Function : Author
Philippe Moreau
  • Function : Author
  • PersonId : 842727
Caroline Bodet-Milin
  • Function : Author
  • PersonId : 938697

Abstract

Radioimmunotherapy represents a potential option as consolidation after chemoimmunotherapy in patients with diffuse large B-cell lymphoma who are not candidates for transplantation. We aimed to assess activity and toxicity of fractionated radioimmunotherapy using anti-CD22 90Y-epratuzumab tetraxetan as consolidation after front-line induction chemoimmunotherapy in untreated elderly patients with diffuse large B-cell lymphoma.
Not file

Dates and versions

hal-02425339 , version 1 (30-12-2019)

Identifiers

Cite

Francoise Kraeber-Bodere, Amandine Pallardy, Hervé Maisonneuve, Loïc Campion, Anne Moreau, et al.. Consolidation anti-CD22 fractionated radioimmunotherapy with 90 Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial. The Lancet Haematology, 2017, 4 (1), pp.e35-e45. ⟨10.1016/S2352-3026(16)30168-5⟩. ⟨hal-02425339⟩
464 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More